1. Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practices in the conduct of clinical trials on medicinal products for human use. Off J 01.05.2001;L 121:34.
2. Directive 2009/41/EC of the European Parliament and of the Council of 6 May 2009 on the contained use of genetically modified micro-organisms (Recast). Off J 21.05.2009;L 125:0075.
3. Directive 2001/18/EC of the European Parliament and of the Council of 12 March on the deliberate release into the environment of genetically modified organisms and repealing Council Directive 90/220/EEC. Off J 17.04.2001;L 106:1.
4. Regulation (EC) No. 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency. Off J 30.04.2004;L 136:1.
5. Modified vaccinia virus Ankara as antigen delivery system: how can we best use its potential?;Drexler;Curr Opin Biotechnol,2004